AstraZeneca PLC 13D and 13G filings for Monopar Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-06 09:54 am Purchase | 2025-12-31 | 13G | MONOPAR THERAPEUTICS INC MNPR | ASTRAZENECA PLC AZN | 522,667 7.800% | 135,338 (+34.94%) | Filing |
| 2024-10-28 06:00 am Purchase | 2024-10-23 | 13G | MONOPAR THERAPEUTICS INC MNPR | ASTRAZENECA PLC AZN | 387,329 9.900% | 387,329 (New Position) | Filing |